Closed call · historical reference
This opportunity involves a procurement contract for Recombinant Coagulation Factor VIII, aimed at businesses and SMEs in Albania. The application is open until June 29, 2026, with a total budget of approximately €42.72 million.
Topics
Partner types
business, sme